Lercaril 10 mg/10 mg film-coated tablets
Authorisation PPA0465/472/001 · PCO Manufacturing Ltd.
- Licence holder
- PCO Manufacturing Ltd. (all products →)
- Active substances
- Enalapril maleate, Lercanidipine hydrochloride
- Clinical trials
- 5 clinical trials → 2 clinical trials →
- Dosage form
- Film-coated tablet
- Route of administration
- Oral use
- ATC codes
- C09BB, C09BB02
- First authorised
- 07/05/2021
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC
Enalapril maleate: supply and approvals
27 authorised products on the HPRA list contain Enalapril maleate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Lercanidipine hydrochloride: supply and approvals
25 authorised products on the HPRA list contain Lercanidipine hydrochloride. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
Parallel import (PPA). A parallel product authorisation: the HPRA allows this product to be imported from another EU or EEA country and sold in Ireland. It has been authorised for 5 years (since 7 May 2021). The HPRA list does not say whether it is on sale.
Other medicines with Enalapril maleate in Ireland
26 other products on the HPRA list contain Enalapril maleate, from 9 licence holders; 15 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| ENAP 10 mg tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| ENAP 20 mg tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| ENAP 5 mg tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Enalapril maleate Accord 10 mg tablets | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Enalapril maleate Accord 20 mg tablets | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Enalapril maleate Accord 5 mg tablets | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Enalapril/Lercanidipine Krka 10 mg/10 mg film-coated tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Enalapril/Lercanidipine Krka 20 mg/10 mg film-coated tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Innovace 10 mg tablets | Organon Pharma (Ireland) Limited | National authorisation (PA) | Marketed |
| Innovace 2.5 mg Tablets | Organon Pharma (Ireland) Limited | National authorisation (PA) | Marketed |
| Innovace 20 mg tablets | Organon Pharma (Ireland) Limited | National authorisation (PA) | Marketed |
| Innovace 5 mg tablets | Organon Pharma (Ireland) Limited | National authorisation (PA) | Marketed |
Other medicines with Lercanidipine hydrochloride in Ireland
22 other products on the HPRA list contain Lercanidipine hydrochloride, from 9 licence holders; 9 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Lecalpin 10 mg film-coated tablets | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Lecalpin 20 mg film-coated tablets | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Lercanidipine Clonmel 10 mg film-coated tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Lercanidipine Clonmel 20 mg film-coated tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Lercaril 10 mg/10 mg film-coated tablets | Recordati Ireland Limited | National authorisation (PA) | Marketed |
| Lercaril 20 mg/10 mg film-coated tablets | Recordati Ireland Limited | National authorisation (PA) | Marketed |
| Lercaril 20 mg/20 mg film-coated tablets | Recordati Ireland Limited | National authorisation (PA) | Marketed |
| Zanidip 10 mg film-coated tablets | Recordati Industria Chimica e Farmaceutica SpA | National authorisation (PA) | Marketed |
| Zanidip 20mg film-coated tablets | Recordati Industria Chimica e Farmaceutica SpA | National authorisation (PA) | Marketed |
| Lercanidipine Hydrochloride Pinewood 10 mg film-coated tablets | Pinewood Laboratories Limited | National authorisation (PA) | Not marketed |
| Lercanidipine Hydrochloride Pinewood 20 mg film-coated tablets | Pinewood Laboratories Limited | National authorisation (PA) | Not marketed |
| Lercaril 10 mg/10 mg film-coated tablets | IMED Healthcare Ltd., | Parallel import (PPA) | Not stated |
Other substances in ATC group C09BB
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 6 other active substances share the group C09BB with this product:
Amlodipine besilate (10) · Perindopril arginine (6) · Perindopril tert-butylamine (4) · Felodipine (4) · Ramipril (4) · Lercanidipine (2)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
PCO Manufacturing Ltd. holds 287 products on the HPRA list, with 163 different active substances; 1 of the products is marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.